Bioequivalence Study Between Adagrasib Reference Tablets and High Drug Load Tablets

Clinical trial NCT06801418 · COMPLETED

Trial details

NCT number: NCT06801418
Sponsor: Mirati Therapeutics Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2025-02-04
Primary completion: 2025-06-19
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.